In vitro studies on the metabolic fate of mifentidine, a novel histamine H2-receptor antagonist

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 22, Issue 2, 1997, Pages 155-164

  Pattichis, K ^a   Kajbaf, M ^a,b   Gorrod, J W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GSK   (Italy)

Author keywords

Amine; Formamide; In vitro metabolism; Mifentidine; Urea

Indexed keywords

DRUG METABOLITE; HISTAMINE H2 RECEPTOR ANTAGONIST; MIFENTIDINE;

ANIMAL TISSUE; ARTICLE; DOG; DRUG METABOLISM; GUINEA PIG; HAMSTER; LIVER MICROSOME; MALE; MONKEY; MOUSE; NONHUMAN; RABBIT; RAT;

EID: 0030800090     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189800     Document Type: Article

References (21)

1. 2-antagonist DA4577, on different in vitro and in vivo preparations. Agents Actions, 14, 510-515.
2. 2-receptor antagonists. J. Med. Chem., 27, 380-386.
3. Del Soldato P., Ghjiorzi A., Cereda E., Donetti A. (1985) : Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models. Pharmacology, 30, 45-51.
4. 2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine. Digestion, 33, 7-16.
5. Bianchi Porro G., Lazzaroni M., Imbimbo B.P., Sangaletti O., Ghirardosi C., Daniotti A. (1987) : Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients. Eur. J. Clin. Pharmacol., 32, 555-558.
6. 2-receptor antagonist mifentidine using tandem mass spectrometry. Anal. Chim. Acta, 247, 151-159.
7. 2-receptor antagonist. PhD Thesis, University of London, UK.
8. Pattichis K., Kajbaf M., Gorrod J.W. (1991) : The in vitro metabolism of mifentidine and two of its derivatives by different species. Prog. Pharmacol. Clin. Pharmacol., 8, 31-40.
9. Kajbaf M., Jahanshahi M., Pattichis K., Gorrod J.W., Naylor S. (1992) : Rapid and efficient purification of cimetropium bromide and mifentidine drug metabolite mixtures derived from microsomal incubates for analysis by mass spectrometry. J. Chromatogr., 575, 75-85.
10. Pattichis K., Louca L.L., Kajbaf M., Gorrod J.W. (1993) : Mifentidine, a formamidine, is metabolised to a urea; a new metabolic pathway. Med. Sci. Res., 21, 747-748.
11. Schenkman J.B., Cinti D.L. (1978) : Preparation of microsomes with calcium. Methods Enzymol., 52, 83-89.
12. Lam S.P., Barlow D.J., Gorrod J.W. (1989) : Conformational analysis of 9-substituted adenines in relation to their microsomal N-oxidation. J. Pharm. Pharmacol., 41, 373-378.
13. Anders M.W., Mannering G.J. (1966) : Inhibition of drug metabolism. 1. Kinetics of the inhibition of N-demethylation of ethylmorphine by 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A) and related compounds. Mol. Pharmacol., 2, 319-327.
14. Buening M.K., Franklin M.R. (1976) : SKF 525-A inhibition, induction and 452 nm complex formation. Drug Metab. Dispos., 4, 244-255.
15. Ziegler D., Poulsen L.L., McKee E.M. (1971) : Interaction of primary amines with a mixed-function amine oxidase isolated from pig liver microsomes. Xenobiotica, 1, 523-531.
16. Gorrod J.W. (1978) : On the multiplicity of N-oxidase systems In: Singer T.P., Ondarzo R.N. (Eds) Developments in Biochemistry, vol. 1 Mechanism of oxidising enzymes. New York: North-Holland/Elsevier, 189-197.
17. Poulsen L.L., Ziegler D.M. (1979) : The liver microsomal FAD-containing monooxygenase. J. Biol. Chem., 254, 6449-6455.
18. Canas-Rodriguez A. (1966) : Preliminary studies on the metabolism of 2-guanidinomethyl-1:4-benzodioxan sulphate (Guanoxan). Experientia, 22, 472-473.
19. Ziegler D.M., Mitchell C.H., Jollow D. (1969) : The properties of a purified hepatic microsomal mixed function amine oxidase. In: Gillette J.R., Conney A.H., Cosmides G.I., Estabrook R.W., Fouts J.R., Mannering G.J. (Eds) Microsomes and Drug Oxidations. New York: Academic Press, 173-188.
20. Naylor S., Tomlinson A.J., Benson L.M., Gorrod J.W. (1994) : Capillary electrophoresis and capillary electrophoresis-mass spectrometry in drug metabolite analysis. Eur. J. Drug Metab. Pharmacokinet., 13, 235-240.
21. Cowan D.A. (1978) : Mass spectrometry as an aid to the identification of N-oxygenated organic molecules. In: Gorrod J.W. (Ed.) Biological Oxidation of Nitrogen. Amsterdam: Elsevier/North Holland, 263-268.